49 related articles for article (PubMed ID: 12526306)
1. Generation of a recombinant rabies Flury LEP virus carrying an additional G gene creates an improved seed virus for inactivated vaccine production.
Tao L; Ge J; Wang X; Wen Z; Zhai H; Hua T; Zhao B; Kong D; Yang C; Bu Z
Virol J; 2011 Sep; 8():454. PubMed ID: 21943337
[TBL] [Abstract][Full Text] [Related]
2. Newcastle disease virus-vectored rabies vaccine is safe, highly immunogenic, and provides long-lasting protection in dogs and cats.
Ge J; Wang X; Tao L; Wen Z; Feng N; Yang S; Xia X; Yang C; Chen H; Bu Z
J Virol; 2011 Aug; 85(16):8241-52. PubMed ID: 21632762
[TBL] [Abstract][Full Text] [Related]
3. A recombinant rabies virus encoding two copies of the glycoprotein gene confers protection in dogs against a virulent challenge.
Liu X; Yang Y; Sun Z; Chen J; Ai J; Dun C; Fu ZF; Niu X; Guo X
PLoS One; 2014; 9(2):e87105. PubMed ID: 24498294
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of cytochrome C by a recombinant rabies virus attenuates pathogenicity and enhances antiviral immunity.
Pulmanausahakul R; Faber M; Morimoto K; Spitsin S; Weihe E; Hooper DC; Schnell MJ; Dietzschold B
J Virol; 2001 Nov; 75(22):10800-7. PubMed ID: 11602721
[TBL] [Abstract][Full Text] [Related]
5. A modified recombinant adenovirus vector containing dual rabies virus G expression cassettes confers robust and long-lasting humoral immunity in mice, cats, and dogs.
Zhang Y; Fang L; Wang Z; Zhang C; Zhao J; Daemi HB; Zhang M; Yuan L; Han X; Li L; Fu ZF; Zhou M; Zhao L
Emerg Microbes Infect; 2024 Dec; 13(1):2300461. PubMed ID: 38164714
[TBL] [Abstract][Full Text] [Related]
6. Glycoprotein of nonpathogenic rabies viruses is a key determinant of human cell apoptosis.
Préhaud C; Lay S; Dietzschold B; Lafon M
J Virol; 2003 Oct; 77(19):10537-47. PubMed ID: 12970438
[TBL] [Abstract][Full Text] [Related]
7. Recombinant rabies virus with the glycoprotein fused with a DC-binding peptide is an efficacious rabies vaccine.
Zhang Y; Zhou M; Li Y; Luo Z; Chen H; Cui M; Fu ZF; Zhao L
Oncotarget; 2018 Jan; 9(1):831-841. PubMed ID: 29416659
[TBL] [Abstract][Full Text] [Related]
8. Combining long-term circuit mapping and network transcriptomics with SiR-N2c.
Lee H; Ciabatti E; González-Rueda A; Williams E; Nugent F; Mookerjee S; Morgese F; Tripodi M
Nat Methods; 2023 Apr; 20(4):580-589. PubMed ID: 36864202
[TBL] [Abstract][Full Text] [Related]
9. Molecular and immunogenic characterization of BHK-21 cell line adapted CVS-11 strain of rabies virus and future prospect in vaccination strategy.
Patel AC; Upmanyu V; Ramasamy S; Gupta PK; Singh R; Singh RP
Virusdisease; 2015 Dec; 26(4):288-96. PubMed ID: 26645040
[TBL] [Abstract][Full Text] [Related]
10. Impact of recombinant Drosophila S2 cell population enrichment on expression of rabies virus glycoprotein.
Santos NG; Rocca MP; Pereira CA; Ventini DC; Puglia AL; Jorge SA; Lemos MA; Astray RM
Cytotechnology; 2016 Dec; 68(6):2605-2611. PubMed ID: 27216014
[TBL] [Abstract][Full Text] [Related]
11. Progress in the Development of Animal Rabies Vaccines in China.
Yin C
China CDC Wkly; 2021 Sep; 3(39):825-830. PubMed ID: 34595001
[No Abstract] [Full Text] [Related]
12. Immune modulating effect by a phosphoprotein-deleted rabies virus vaccine vector expressing two copies of the rabies virus glycoprotein gene.
Cenna J; Tan GS; Papaneri AB; Dietzschold B; Schnell MJ; McGettigan JP
Vaccine; 2008 Nov; 26(50):6405-14. PubMed ID: 18804506
[TBL] [Abstract][Full Text] [Related]
13. Expression of glycoprotein gene of the rabies virus 3aG strain by E-3 deleted adenovirus recombinant.
Zhang X; Zhang Y; Li W
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Sep; 14(3):281-4. PubMed ID: 11498699
[TBL] [Abstract][Full Text] [Related]
14. [Recombinant replication-defective adenovirus based rabies vaccine].
Li WH; Zhang Y; Wang SH; Liu L; Yang F
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Dec; 25(6):650-4. PubMed ID: 14714304
[TBL] [Abstract][Full Text] [Related]
15. A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier.
Xiang ZQ; Yang Y; Wilson JM; Ertl HC
Virology; 1996 May; 219(1):220-7. PubMed ID: 8623532
[TBL] [Abstract][Full Text] [Related]
16. Canine adenovirus based rabies vaccines.
Tordo N; Foumier A; Jallet C; Szelechowski M; Klonjkowski B; Eloit M
Dev Biol (Basel); 2008; 131():467-76. PubMed ID: 18634509
[TBL] [Abstract][Full Text] [Related]
17. New approaches to the development of live attenuated rabies vaccines.
Dietzschold B; Schnell MJ
Hybrid Hybridomics; 2002 Apr; 21(2):129-34. PubMed ID: 12031103
[TBL] [Abstract][Full Text] [Related]
18. [Immune response of mice to replication-defective recombinant adenovirus containing glycoprotein gene of rabies virus 3aG strain].
Li W; Zhang Y; Wang S
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Mar; 15(1):61-5. PubMed ID: 12526306
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
